InflaRx N.V. (IFRX) vs Immuneering Corporation (IMRX)
InflaRx N.V. and Immuneering Corporation are both Biotechnology companies. InflaRx N.V. and Immuneering Corporation are of similar size ($284.4M and $280.8M). InflaRx N.V. grew revenue faster over the last twelve months: −83.4% against −84.8%. Across the 13 metrics below, InflaRx N.V. leads on 7 and Immuneering Corporation on 6.
Valuation
Profitability
| Metric | IFRX | IMRX | Biotechnology median |
|---|---|---|---|
| Gross margin | (26,762.42%) | 0.00% | 65.16% |
| Operating margin | 0.00% | 0.00% | 0.00% |
| Net margin | 0.00% | 0.00% | 0.00% |
| Free cash flow margin | 0.00% | 0.00% | 0.00% |
| Return on equity | (38.71%) | (52.15%) | (57.72%) |
| Return on assets | (32.75%) | (47.31%) | (49.22%) |
| Return on invested capital | 0.00% | (97.14%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack